More than 100 million Americans who qualify as overweight could see themselves tip into the obese category under newly ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...

Dr. David Geier joined Good morning Charleston Wednesday to break down a new study and talk about some of the myths surrounding a persons BMI and what measureme ...

Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...

Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...

The advice to “eat less, move more” isn’t just outdated, it’s harmful. Obesity is a chronic condition shaped by biology, ...

Understanding the link between obesity, fatty liver disease and kidney stones provides a new perspective on prevention and ...

Rhythm Pharmaceuticals shares surged to a record high Wednesday on promising results for a drug that could treat a rare form ...

Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...

Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...